Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver.
Shen S, Dai H, Fei Z, Chai Y, Hao Y, Fan Q, Dong Z, Zhu Y, Xu J, Ma Q, Han X, Xu L, Peng F, Liu Z, Wang C.
Shen S, et al. Among authors: xu l, xu j.
ACS Nano. 2021 May 25;15(5):9111-9125. doi: 10.1021/acsnano.1c02391. Epub 2021 May 14.
ACS Nano. 2021.
PMID: 33988024